000 | 01246 a2200301 4500 | ||
---|---|---|---|
005 | 20250516072230.0 | ||
264 | 0 | _c20120913 | |
008 | 201209s 0 0 eng d | ||
022 | _a1549-781X | ||
024 | 7 |
_a10.3109/10408363.2011.646942 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFaiz, Fathimath | |
245 | 0 | 0 |
_aMolecular pathology of familial hypercholesterolemia, related dyslipidemias and therapies beyond the statins. _h[electronic resource] |
260 |
_bCritical reviews in clinical laboratory sciences _c |
||
300 |
_a1-17 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 |
_aDyslipidemias _xdrug therapy |
650 | 0 | 4 | _aGenetic Predisposition to Disease |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xtherapeutic use |
650 | 0 | 4 |
_aHyperlipoproteinemia Type II _xdrug therapy |
650 | 0 | 4 |
_aRNA Splice Sites _xgenetics |
650 | 0 | 4 |
_aReceptors, LDL _xgenetics |
700 | 1 | _aHooper, Amanda J | |
700 | 1 | _avan Bockxmeer, Frank M | |
773 | 0 |
_tCritical reviews in clinical laboratory sciences _gvol. 49 _gno. 1 _gp. 1-17 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3109/10408363.2011.646942 _zAvailable from publisher's website |
999 |
_c21432575 _d21432575 |